Sustainable Development

An epidemiologist from Uganda, Dr. Monica Musenero Masanza known as ‘KORNYA’ meaning in Mende tribe female warrior was the brain behind the successes against the Ebola Virus Disease (EVD) outbreak in Kenema district and other parts of the country.
Dr. Monica once again paid visit to Kenema district on Saturday, 2nd April 2016 together with her husband, Dr. Michael Masanza to reflect on her work in the Ebola Task Force team that was set up in Kenema district during the fight to contain the Ebola outbreak in the district.
Meeting with stakeholders in Kenema at the office of the Mayor of Kenema City Council, all present rained words of praises on Dr. Monica and family for allowing her to come to Sierra Leone to help Sierra Leonean during the Ebola crisis.
Making statement Augustine Sannoh regional chairman civil society organization says while in Ghana he received called from Dr. Monica that her husband is on her way to Sierra Leone particularly Kenema to see the team she worked with during the Ebola fight in the country.

After being declared Ebola-free months ago, Senegal is still relentless in controlling any possible outbreak of the Ebola virus in its country.

With a dozen tents and twelve beds surrounded by a double fence, an Ebola emergency treatment centre has been built in the Fann Hospital in Dakar to contain the virus in case it penetrates the country’s porous borders,RFI reports.

The centre, a partnership between the government, Red Cross and the Japanese cooperation, will also be used for outbreaks associated with other infectious diseases.

For more than a month in 2015, a multidisciplinary team including infectious disease and critical care physicians and nurses, respiratory therapists and other specialists at the National Institutes of Health (NIH) treated a critically ill patient who had contracted Ebola virus disease in Sierra Leone. A new report by the medical caregivers details the clinical course of the 34-year-old American healthcare worker who was admitted to the NIH Special Clinical Studies Unit on day 7 of his illness. The patient survived his illness with intensive supportive care, despite multi-organ failure.

Upon admission to the NIH Clinical Center, the patient was enrolled in a clinical trial and was randomly assigned to receive optimized supportive care only. The trial's other arm included treatment with experimental therapies. In the first few days after admission, the patient's condition worsened dramatically and he experienced sequential organ failure, despite intensive supportive care that included maintenance of optimal fluid and electrolyte balances. His prognosis was poor.